OPKO HEALTH, INC. - Common Stock, par value $0.01 per share (OPK)

Historical Holders from Q1 2014 to Q3 2025

Symbol
OPK on Nasdaq
Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
771M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
196M
Holdings value
$304M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
227
Number of buys
102
Number of sells
-66
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of OPKO HEALTH, INC. - Common Stock, par value $0.01 per share (OPK)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FROST PHILLIP MD ET AL 32.8% +3.44% $352M $674K 253M +0.19% FROST PHILLIP MD ET AL 30 Sep 2025
Rubric Capital Management LP 6.03% $63.1M 47.8M Rubric Capital Management LP 30 Jun 2025
HSIAO JANE PH D 4.5% $50.3M 35.7M HSIAO JANE PH D 02 Apr 2025

Institutional Holders of OPKO HEALTH, INC. - Common Stock, par value $0.01 per share (OPK)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 196M $304M -$11.8M $1.55 227
2025 Q2 205M $271M -$60.6M $1.32 215
2025 Q1 241M $401M +$72.1M $1.66 247
2024 Q4 197M $290M +$15.9M $1.47 230
2024 Q3 187M $278M +$7.88M $1.49 227
2024 Q2 182M $228M +$32.3M $1.25 227
2024 Q1 158M $190M -$15.4M $1.20 218
2023 Q4 170M $257M +$2.95M $1.51 211
2023 Q3 167M $267M -$11.7M $1.60 219
2023 Q2 173M $375M -$7.39M $2.17 224
2023 Q1 178M $259M -$3.08M $1.46 218
2022 Q4 181M $227M -$10.2M $1.25 214
2022 Q3 187M $352M -$8.9M $1.89 200
2022 Q2 190M $480M -$13.9M $2.53 210
2022 Q1 195M $670M +$10.9M $3.44 215
2021 Q4 190M $915M +$32.7M $4.81 222
2021 Q3 183M $669M -$29.2M $3.65 196
2021 Q2 191M $773M +$54.9K $4.05 224
2021 Q1 190M $817M +$5.25M $4.29 230
2020 Q4 188M $742M -$29.9M $3.95 229
2020 Q3 196M $721M -$13.3M $3.69 207
2020 Q2 199M $679M +$131M $3.41 198
2020 Q1 162M $217M -$19.7M $1.34 167
2019 Q4 176M $259M +$42M $1.47 185
2019 Q3 147M $308M -$17.1M $2.09 173
2019 Q2 155M $377M -$4.45M $2.44 185
2019 Q1 159M $415M +$39.4M $2.61 185
2018 Q4 142M $427M -$32.2M $3.01 187
2018 Q3 152M $526M +$32M $3.46 197
2018 Q2 141M $663M +$30.4M $4.70 202
2018 Q1 135M $427M +$21.8M $3.17 210
2017 Q4 131M $641M -$11.9M $4.90 217
2017 Q3 132M $902M +$9.81M $6.86 228
2017 Q2 127M $838M -$14.5M $6.58 221
2017 Q1 131M $1.05B +$159M $8.00 232
2016 Q4 133M $1.24B +$47.4M $9.30 241
2016 Q3 127M $1.35B +$129M $10.59 260
2016 Q2 115M $1.08B +$41.6M $9.34 234
2016 Q1 109M $1.14B -$48.2M $10.39 248
2015 Q4 116M $1.16B -$135M $10.05 266
2015 Q3 123M $1.03B +$270M $8.41 256
2015 Q2 85.4M $1.37B +$79.6M $16.08 215
2015 Q1 80.7M $1.14B +$43.8M $14.17 189
2014 Q4 78M $780M +$30.1M $9.99 175
2014 Q3 74.7M $636M -$64.4M $8.51 180
2014 Q2 81.8M $723M +$87M $8.84 171
2014 Q1 72.8M $678M +$9.37M $9.32 165